Skip to main content

tooluniverse-cell-line-profiling

Cancer cell-line selection and profiling for experimental model choice. Cross-references DepMap, Cellosaurus, COSMIC, PharmacoDB to deliver identity verification, mutation/CNV profile, gene dependencies, drug sensitivities, and druggable targets. Use to answer 'which cell line should I use for studying gene X?' or 'is this cell line a good model for cancer Y?'. Outputs ranked recommendations with rationale, growth characteristics, and known pitfalls.

소스 정보

저장소
mims-harvard/ToolUniverse
최근 소스 활동
2026년 10월 6일 14:13
감지된 SKILL.md 언어
영어
스타
1,727
포크
262

설치 방법

기본적으로 소스를 먼저 확인하는 Prompt가 선택됩니다. 직접 명령으로 전환하거나 로컬 사본을 다운로드할 수도 있습니다.

소스 파일 검토

설치 여부를 결정하기 전에 SKILL.md와 SkillsMP에 표시된 보조 파일을 읽어 보세요.

파일 탐색기
2 개 파일

SKILL.md 표시 중

SKILL.md
소스 지침 · 읽기 전용 미리보기
name
tooluniverse-cell-line-profiling
description
Cancer cell-line selection and profiling for experimental model choice. Cross-references DepMap, Cellosaurus, COSMIC, PharmacoDB to deliver identity verification, mutation/CNV profile, gene dependencies, drug sensitivities, and druggable targets. Use to answer 'which cell line should I use for studying gene X?' or 'is this cell line a good model for cancer Y?'. Outputs ranked recommendations with rationale, growth characteristics, and known pitfalls.
disable-model-invocation
true
# Cancer Cell Line Profiling and Selection Comprehensive profiling of cancer cell lines for experimental model selection. Transforms a query (cancer type, gene, or cell line name) into an actionable report covering identity verification, molecular features, gene dependencies, drug sensitivities, and druggable targets. **KEY PRINCIPLES**: 1. **Decision-first** - Answer "which cell line should I use?" not "here is all the data" 2. **Multi-source validation** - Cross-reference DepMap, Cellosaurus, COSMIC, PharmacoDB 3. **Actionable output** - Ranked cell line recommendations with rationale 4. **Practical focus** - Include availability, growth characteristics, common pitfalls 5. **Gene-aware** - When a gene of interest is given, prioritize lines with relevant mutations/dependencies 6. **Source-referenced** - Cite database sources for every claim 7. **English-first queries** - Always use English terms in tool calls, even if the user writes in another language ## LOOK UP, DON'T GUESS When uncertain about any scientific fact, SEARCH databases first rather than reasoning from memory. A database-verified answer is always more reliable than a guess. --- ## COMPUTE, DON'T DESCRIBE When analysis requires computation (statistics, data processing, scoring, enrichment), write and run Python code via Bash. Don't describe what you would do — execute it and report actual results. Use ToolUniverse tools to retrieve data, then Python (pandas, scipy, statsmodels, matplotlib) to analyze it. ## When to Use Apply for: cell line selection by cancer type/gene, cell line profiling, gene dependencies, drug sensitivity queries, cell line comparisons, mutation checks. --- ## Phase 0: Tool Parameter Reference (CRITICAL) **BEFORE calling ANY tool**, verify parameters against this table. | Tool | Key Parameters | Notes | |------|---------------|-------| | `DepMap_search_cell_lines` | `query` (required) | Search by name, e.g., "A549", "MCF" | | `DepMap_get_cell_line` | `model_name` OR `model_id` | Name: "A549"; ID: "SIDM00001" | | `DepMap_get_cell_lines` | `tissue`, `cancer_type`, `page_size` | Filter by tissue (e.g., "Lung") | | `DepMap_get_gene_dependencies` | `gene_symbol` (required), `model_id` | Gene effect scores; negative = essential | | `DepMap_search_genes` | `query` (required) | Validate gene symbol in DepMap first | | `cellosaurus_search_cell_lines` | `q` (required), `size` | Solr syntax: `id:HeLa`, `ox:9606 AND char:cancer` | | `cellosaurus_get_cell_line_info` | `accession` (required, CVCL_ format) | Full cell line record | | `cellosaurus_query_converter` | `query` (required) | Natural language to Solr syntax | | `COSMIC_search_mutations` | `terms` OR `query`, `max_results` | Search "BRAF V600E" or gene name | | `COSMIC_get_mutations_by_gene` | `gene` OR `gene_name`, `max_results` | All mutations for a gene | | `PharmacoDB_get_cell_line` | `operation="get_cell_line"`, `cell_name` | Cell line metadata + datasets | | `PharmacoDB_get_experiments` | `operation="get_experiments"`, `compound_name`, `cell_line_name`, `dataset_name`, `per_page` | Drug response data (IC50, AAC, EC50) | | `PharmacoDB_get_biomarker_assoc` | `operation="get_biomarker_associations"`, `compound_name`, `tissue_name`, `mdata_type`, `per_page` | Gene-drug sensitivity correlations | | `PharmacoDB_search` | `operation="search"`, `query` | Find PharmacoDB IDs | | `CellMarker_search_cancer_markers` | `operation="search_cancer_markers"`, `cancer_type`, `gene_symbol`, `cell_type` | Cancer cell markers | | `CellMarker_search_by_gene` | `operation="search_by_gene"`, `gene_symbol` (required), `species` | Cell types expressing a gene | | `HPA_get_comparative_expression_by_gene_and_cellline` | `gene_name` (required), `cell_line` (required) | Supported lines: ishikawa, hela, mcf7, a549, hepg2, jurkat, pc3, rh30, siha, u251 | | `SYNERGxDB_search_combos` | `drug_name_1`, `drug_name_2`, `sample` (tissue or cell ID) | Drug combination synergy (ZIP, Bliss, Loewe) | | `SYNERGxDB_list_cell_lines` | - | All cell lines in SYNERGxDB | | `DGIdb_get_drug_gene_interactions` | `genes: list[str]` | Druggable gene interactions | | `OpenTargets_get_associated_drugs_by_target_ensemblID` | `ensemblId`, `size` | Drugs targeting a gene | | `STRING_get_network` | `protein_ids: list[str]`, `species: int` (9606) | PPI network for gene context | | `MyGene_query_genes` | `query` (NOT `q`) | Resolve gene symbol to Ensembl ID | | `cBioPortal_get_mutations` | `study_id`, `gene_list` (STRING, not array) | Cell line mutations from CCLE | --- ## Workflow Overview ``` Input: Cancer type AND/OR Gene of interest AND/OR Cell line name(s) Phase 1: Cell Line Identification - Search and verify cell line identity (Cellosaurus) - Get metadata: species, disease, STR profile, cross-references - If cancer type given without cell line: find candidate lines (DepMap) Phase 2: Molecular Profiling - Mutation landscape (COSMIC, cBioPortal CCLE) - Gene expression (HPA, DepMap) - Cancer markers (CellMarker) Phase 3: Gene Dependencies (CRISPR Screens) - Gene essentiality scores from DepMap - Identify selectively essential genes - Compare across cell lines if multiple candidates Phase 4: Drug Sensitivity - IC50/AAC from PharmacoDB (GDSC, CCLE, CTRPv2, PRISM) - Biomarker associations for drug response - Drug combination synergy (SYNERGxDB) Phase 5: Target Druggability & Recommendations - Druggable targets (DGIdb, OpenTargets) - Final ranked recommendation with rationale ``` --- ## Phase 1: Cell Line Identification **Goal**: Verify cell line identity and find candidates. **If specific cell line given**: (1) `cellosaurus_search_cell_lines(q="id:<NAME>")` → get CVCL accession, species, disease, contamination flags. (2) `cellosaurus_get_cell_line_info(accession="CVCL_XXXX")` for STR profile. (3) `DepMap_get_cell_line(model_name="...")` for tissue, cancer_type, MSI, ploidy. (4) `PharmacoDB_get_cell_line(operation="get_cell_line", cell_name="...")` for datasets. **If cancer type only**: (1) `DepMap_get_cell_lines(tissue="Lung", page_size=20)`. (2) Narrow by gene mutations/dependencies in Phases 2-3. (3) `CellMarker_search_cancer_markers(operation="search_cancer_markers", cancer_type="Lung")`. **OUTPUT**: Table of candidate cell lines with: name, tissue, cancer type, key identifiers. --- ## Phase 2: Molecular Profiling **Goal**: Characterize mutational and expression landscape. **2A Mutations**: `COSMIC_get_mutations_by_gene(gene="EGFR")` + `cBioPortal_get_mutations(study_id="ccle_broad_2019", gene_list="EGFR,KRAS,TP53")`. Note: `gene_list` is a comma-separated STRING. CCLE study ID: `ccle_broad_2019`. **2B Expression**: `HPA_get_comparative_expression_by_gene_and_cellline(gene_name="EGFR", cell_line="a549")`. Only 10 lines supported: hela, mcf7, a549, hepg2, jurkat, pc3, rh30, siha, u251, ishikawa. **2C Cancer markers**: `CellMarker_search_by_gene(operation="search_by_gene", gene_symbol="EGFR", species="Human")` **OUTPUT**: Mutation table (gene, AA change, type) + expression summary per cell line. --- ## Phase 3: Gene Dependencies (CRISPR Screens) **Goal**: Determine which genes are essential in candidate cell lines. **LIMITATION**: `DepMap_get_gene_dependencies` returns gene metadata (HGNC ID, Ensembl ID) but NOT per-cell-line CRISPR scores. Full Chronos scores require depmap.org download. **Available tools**: (1) `DepMap_search_genes(query="EGFR")` — validate gene exists. (2) `DepMap_get_gene_dependencies(gene_symbol="EGFR")` — metadata only. (3) **Alternatives**: cBioPortal CCLE for mutation data, PubMed for published screens, or direct user to depmap.org/portal. **Interpreting Chronos scores** (from DepMap portal): <-0.5 = essential; ~0 = not essential; ~-1.0 = strongly essential. Selective dependency (essential in some lineages only) indicates therapeutic window. **OUTPUT**: Gene validation + mutation status per cell line. **Per-cell-line Chronos scores** (what the API can't give you): use the bundled script `scripts/depmap_gene_dependency.py`. It pulls the current DepMap Public release (CRISPRGeneEffect.csv + Model.csv) once via the public download index, caches it, and answers the dependency question directly: NOTE (2026-09-21): DepMap's download index now answers with a bot-check page instead of the file list; the script reports that (exit 2) rather than bypassing it. Download `CRISPRGeneEffect.csv` and `Model.csv` from https://depmap.org/portal/download/all/ in a browser and put them in the cache directory (`$DEPMAP_CACHE_DIR`, default `<tmp>/depmap_cache`); cached files are used without contacting DepMap. ```bash # Cell lines most dependent on a gene (optionally within a lineage) python scripts/depmap_gene_dependency.py gene KRAS --lineage Pancreas --top 20 # Genes a given cell line is most dependent on python scripts/depmap_gene_dependency.py cell-line A375 --top 25 ``` Output: cell line, lineage, primary disease, Chronos score (most negative = most dependent; < -0.5 ≈ dependency). For selective-dependency reasoning, compare a gene's scores across lineages. **If DepMap data is unavailable**: Use `cBioPortal_get_mutations(study_id="ccle_broad_2019", gene_list="KRAS")` for mutation data, and the Quick Reference table below for common recommendations. --- ## Phase 4: Drug Sensitivity **Goal**: Profile drug response data. **4A PharmacoDB**: `PharmacoDB_get_experiments(operation="get_experiments", compound_name="Erlotinib", cell_line_name="A549", per_page=20)` for dose-response (IC50, AAC, EC50). Omit `compound_name` to get all drugs for a cell line. Use `PharmacoDB_get_biomarker_assoc(compound_name="...", tissue_name="...", mdata_type="mutation")` for sensitivity biomarkers. **4B SYNERGxDB**: `SYNERGxDB_search_combos(drug_name_1="gemcitabine", drug_name_2="erlotinib", sample="lung")`. Positive ZIP = synergy. Covers cytotoxic agents only (not targeted therapies/biologics). **OUTPUT**: Drug sensitivity table (drug, IC50, AAC, dataset) + synergy data if available. --- ## Phase 5: Target Druggability and Recommendations **5A Druggability**: `DGIdb_get_drug_gene_interactions(genes=["EGFR", "KRAS"])` + `MyGene_query_genes(query="EGFR")` → `OpenTargets_get_associated_drugs_by_target_ensemblID(ensemblId="...", size=10)` + `STRING_get_network(protein_ids=["EGFR"], species=9606)`. **5B Final Recommendation**: Synthesize all phases. **Explain WHY one line is better for this specific use case.** #### Decision Criteria with Concrete Thresholds | Criterion | Weight | Score 3 (Best) | Score 2 (Acceptable) | Score 1 (Poor) | |-----------|--------|----------------|---------------------|----------------| | **Mutation match** | x3 | Exact mutation (e.g., KRAS G12D) | Same gene, different mutation | No mutation in gene of interest | | **Co-mutation simplicity** | x2 | Few co-mutations (cleaner background) | Moderate co-mutations | Complex background (3+ driver mutations) | | **Gene dependency** | x2 | DepMap score < -0.5 (essential) | Score -0.5 to -0.2 (moderately essential) | Score > -0.2 (not essential) | | **Drug sensitivity data** | x1 | In GDSC + CCLE + PRISM (3+ datasets) | In 1-2 datasets | No drug response data | | **Practical factors** | x1 | Adherent, well-characterized, widely used | Suspension or less common | Hard to culture, contamination-prone | **Total score** = sum of (criterion score × weight). Max = 27. Rank cell lines by total score. #### Use-Case-Specific Guidance The best cell line depends on what you're doing with it: | Use Case | Key Requirements | Extra Considerations | |----------|-----------------|---------------------| | **CRISPR knockout screen** | Adherent growth, good lentiviral transduction, pre-existing Cas9 clones (check Cellosaurus for "-Cas9" derivatives) | Doubling time matters for library coverage; <72h ideal | | **Drug sensitivity testing** | In PharmacoDB/GDSC, known IC50 for reference compounds | Check SYNERGxDB for combo data | | **Xenograft model** | Known tumorigenicity in mice, available PDX data | Check if line forms tumors in nude/NSG mice (Cellosaurus often notes this) | | **Mechanism of action** | Clean genetic background, gene dependency confirmed | Fewer co-mutations = easier to attribute phenotypes | | **Biomarker discovery** | Isogenic pairs available, well-characterized omics | Check if isogenic knockouts exist (Cellosaurus) | | **Drug combination** | In SYNERGxDB with combo data, known single-agent responses | ZIP score available for synergy assessment | #### Cellosaurus Derivative Lines **Check for pre-made derivatives** — this can save months of lab work:
GitHub에서 보기
이 SKILL.md는 매우 커서 SkillsMP가 여기에는 첫 섹션만 미리 보여줍니다. GitHub에서 보기